EP 3700899 A1 20200902 - SUBSTITUTED TRIAZOLE DERIVATIVES AND USES THEREOF
Title (en)
SUBSTITUTED TRIAZOLE DERIVATIVES AND USES THEREOF
Title (de)
SUBSTITUIERTE TRIAZOLDERIVATE UND DEREN VERWENDUNGEN
Title (fr)
DÉRIVÉS DE TRIAZOLE SUBSTITUÉS ET UTILISATIONS ASSOCIÉES
Publication
Application
Priority
- EP 17197949 A 20171024
- EP 2018078415 W 20181017
Abstract (en)
[origin: WO2019081306A1] The present invention relates to novel substituted 1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and cardiovascular diseases.
IPC 8 full level
C07D 401/14 (2006.01); A61K 31/4196 (2006.01); A61P 9/00 (2006.01); A61P 13/00 (2006.01); C07D 403/06 (2006.01); C07D 403/14 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01)
CPC (source: EP US)
A61K 31/4196 (2013.01 - EP); A61K 45/06 (2013.01 - EP US); A61P 9/00 (2017.12 - EP); A61P 9/10 (2017.12 - US); A61P 13/00 (2017.12 - EP); C07D 401/14 (2013.01 - EP US); C07D 403/06 (2013.01 - EP US); C07D 403/14 (2013.01 - EP US); C07D 405/14 (2013.01 - EP US); C07D 413/14 (2013.01 - EP US)
Citation (search report)
See references of WO 2019081306A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2019081306 A1 20190502; CA 3079771 A1 20190502; EP 3700899 A1 20200902; US 11230540 B2 20220125; US 2021179590 A1 20210617
DOCDB simple family (application)
EP 2018078415 W 20181017; CA 3079771 A 20181017; EP 18785400 A 20181017; US 201816758744 A 20181017